![]() |
Name |
(1S,4S,5S,7R,8S,12R)-5,12-dihydroxy-4-methyl-7-prop-1-en-2-yl-3,14-dioxatetracyclo[10.2.1.02,10.04,8]pentadec-2(10)-en-11-one
|
Molecular Formula | C17H22O5 | |
IUPAC Name* |
(1S,4S,5S,7R,8S,12R)-5,12-dihydroxy-4-methyl-7-prop-1-en-2-yl-3,14-dioxatetracyclo[10.2.1.02,10.04,8]pentadec-2(10)-en-11-one
|
|
SMILES |
CC(=C)[C@@H]1C[C@@H]([C@@]2([C@H]1CC3=C(O2)[C@@H]4C[C@](C3=O)(CO4)O)C)O
|
|
InChI |
InChI=1S/C17H22O5/c1-8(2)9-5-13(18)16(3)11(9)4-10-14(22-16)12-6-17(20,7-21-12)15(10)19/h9,11-13,18,20H,1,4-7H2,2-3H3/t9-,11-,12-,13-,16-,17+/m0/s1
|
|
InChIKey |
IGDRQSDOUVIHQM-VMEHZNMRSA-N
|
|
Synonyms |
CHEMBL3754388
|
|
CAS | NA | |
PubChem CID | 127035630 | |
ChEMBL ID | CHEMBL3754388 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 306.4 | ALogp: | 0.6 |
HBD: | 2 | HBA: | 5 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 76.0 | Aromatic Rings: | 4 |
Heavy Atoms: | 22 | QED Weighted: | 0.719 |
Caco-2 Permeability: | -4.916 | MDCK Permeability: | 0.00001350 |
Pgp-inhibitor: | 0.018 | Pgp-substrate: | 0.846 |
Human Intestinal Absorption (HIA): | 0.017 | 20% Bioavailability (F20%): | 0.009 |
30% Bioavailability (F30%): | 0.119 |
Blood-Brain-Barrier Penetration (BBB): | 0.875 | Plasma Protein Binding (PPB): | 58.74% |
Volume Distribution (VD): | 1.193 | Fu: | 47.62% |
CYP1A2-inhibitor: | 0.023 | CYP1A2-substrate: | 0.533 |
CYP2C19-inhibitor: | 0.023 | CYP2C19-substrate: | 0.788 |
CYP2C9-inhibitor: | 0.009 | CYP2C9-substrate: | 0.031 |
CYP2D6-inhibitor: | 0.003 | CYP2D6-substrate: | 0.084 |
CYP3A4-inhibitor: | 0.025 | CYP3A4-substrate: | 0.484 |
Clearance (CL): | 5.622 | Half-life (T1/2): | 0.272 |
hERG Blockers: | 0.219 | Human Hepatotoxicity (H-HT): | 0.905 |
Drug-inuced Liver Injury (DILI): | 0.657 | AMES Toxicity: | 0.35 |
Rat Oral Acute Toxicity: | 0.819 | Maximum Recommended Daily Dose: | 0.827 |
Skin Sensitization: | 0.372 | Carcinogencity: | 0.763 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.026 |
Respiratory Toxicity: | 0.891 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002719 | ![]() |
0.686 | D0P0HT | ![]() |
0.257 | ||
ENC003338 | ![]() |
0.635 | D03HYX | ![]() |
0.239 | ||
ENC006127 | ![]() |
0.595 | D03BLF | ![]() |
0.239 | ||
ENC006129 | ![]() |
0.564 | D0IT2G | ![]() |
0.239 | ||
ENC003341 | ![]() |
0.554 | D0FL5V | ![]() |
0.239 | ||
ENC002720 | ![]() |
0.538 | D07DVK | ![]() |
0.239 | ||
ENC003657 | ![]() |
0.538 | D0CW1P | ![]() |
0.239 | ||
ENC002721 | ![]() |
0.532 | D0V9DZ | ![]() |
0.231 | ||
ENC006126 | ![]() |
0.506 | D0CZ1Q | ![]() |
0.231 | ||
ENC003344 | ![]() |
0.469 | D08PIQ | ![]() |
0.231 |